Published in Ann Rheum Dis on August 01, 1986
Late onset systemic lupus erythematosus: no substantial differences using different cut-off ages. Rheumatol Int (2006) 0.84
Systemic lupus erythematosus presenting as polymyalgia rheumatica. Ann Rheum Dis (1987) 0.75
Pleuropericardial effusion: an unusual presentation of polymyalgia rheumatica. BMJ Case Rep (2014) 0.75
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) (1954) 8.18
SYSTEMIC LUPUS ERYTHEMATOSUS. A STATISTICAL EVALUATION OF MORTALITY BASED ON A CONSECUTIVE SERIES OF 299 PATIENTS. Arch Intern Med (1964) 1.93
Polymyalgia rheumatica. A manifestation of systemic giant-cell arteritis. Ann Intern Med (1967) 1.87
Clinical features of systemic lupus erythematosus: differences related to race and age of onset. Arthritis Rheum (1982) 1.71
The clinical significance of autoantibodies to a soluble cytoplasmic antigen in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol (1979) 1.51
Autoantibodies and the spectrum of Sjögren's syndrome. Ann Intern Med (1979) 1.44
Systemic lupus erythematosus in the elderly: clinical and serological characteristics. J Rheumatol (1984) 1.27
Systemic lupus erythematosus in the elderly. Arch Intern Med (1972) 1.08
Polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum (1971) 1.04
Late-life myopathy occurring with Sjogren's syndrome. Arch Neurol (1962) 0.95
A disease severity scale for systemic sclerosis: development and testing. J Rheumatol (1999) 2.85
Abnormal hypothalamic-pituitary-adrenal axis function in rheumatoid arthritis. Effects of nonsteroidal antiinflammatory drugs and water immersion. Arthritis Rheum (1994) 2.30
Serological findings in patients with "ANA-negative" systemic lupus erythematosus. Medicine (Baltimore) (1981) 2.27
Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med (1982) 2.26
Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med (1983) 2.24
Anti-inflammatory lipocortin 1 production by peripheral blood leucocytes in response to hydrocortisone. Lancet (1990) 1.88
Arthropathy of hands and feet in systemic lupus erythematosus. J Rheumatol (1990) 1.74
Serologic subsets in systemic lupus erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens. Arthritis Rheum (1980) 1.62
Apatite associated destructive arthritis. Br J Rheumatol (1984) 1.61
Anti-Ro(SSA) positive rheumatoid arthritis (RA): a clinicoserological group of patients with high incidence of D-penicillamine side effects. Ann Rheum Dis (1985) 1.56
Serological markers in progressive systemic sclerosis: clinical correlations. Ann Rheum Dis (1983) 1.55
Factor VIII related antigen in connective tissue disease patients and relatives. Br J Rheumatol (1990) 1.55
Vitamin D deficiency, spontaneous fractures, and osteopenia in rheumatoid arthritis. Br Med J (1974) 1.53
Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies. Ann Rheum Dis (1987) 1.49
Sjögren's syndrome: association with type-1 diabetes mellitus. Br J Rheumatol (1989) 1.48
Infrared thermography: what is its place in rheumatology in the 1990s? Br J Rheumatol (1992) 1.44
99mTc HMDP bone scanning in generalised nodal osteoarthritis. II. The four hour bone scan image predicts radiographic change. Ann Rheum Dis (1986) 1.43
Radiological progression in rheumatoid arthritis: do D-penicillamine and hydroxychloroquine have different effects? Br J Rheumatol (1990) 1.40
Limited forms of Wegener's granulomatosis presenting as polymyalgia rheumatica. Br J Rheumatol (1991) 1.39
A case of lymphomatoid granulomatosis with a protracted course and prominent CNS involvement. Br J Rheumatol (1989) 1.39
Atypical antineutrophil cytoplasmic antibodies in patients with ankylosing spondylitis. Br J Rheumatol (1995) 1.38
Silica-associated systemic sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis. Br J Dermatol (1990) 1.33
Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes. J Clin Immunol (1984) 1.30
Anticardiolipin antibodies, livedo reticularis, and major cerebrovascular and renal disease in systemic lupus erythematosus. Ann Rheum Dis (1988) 1.30
Systemic lupus erythematosus in the elderly: clinical and serological characteristics. J Rheumatol (1984) 1.27
Deposition of antibodies to a soluble cytoplasmic antigen in the kidneys of patients with systemic lupus erythematosus. Arthritis Rheum (1979) 1.26
Circulating von Willebrand factor in inflammatory bowel disease. Gut (1992) 1.26
Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients. Ann Rheum Dis (1990) 1.21
A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases. Ann Rheum Dis (1991) 1.20
Quantitation of precipitating antibodies to certain soluble nuclear antigens in SLE. Arthritis Rheum (1977) 1.18
The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associations. Medicine (Baltimore) (1990) 1.17
Antibodies to cytoplasmic antigens in lupus erythematosus. Serologic marker for systemic disease. Arthritis Rheum (1977) 1.13
Antibodies to nRNP, Sm, Ro(SSA) and La(SSB) detected by ELISA: their specificity and inter-relations in connective tissue disease sera. Clin Exp Immunol (1985) 1.13
The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner. J Immunol Methods (1986) 1.13
HLA DQ alpha and DQ beta restriction fragment length polymorphisms associated with Felty's syndrome and DR4-positive rheumatoid arthritis. Hum Immunol (1987) 1.11
A randomized and controlled trial of hydrotherapy in rheumatoid arthritis. Arthritis Care Res (1996) 1.05
HLA antigens, autoantibodies and clinical subsets in scleroderma. Br J Rheumatol (1984) 1.03
99mTc HMDP bone scanning in generalised nodal osteoarthritis. I. Comparison of the standard radiograph and four hour bone scan image of the hand. Ann Rheum Dis (1986) 1.01
Differential isotype recognition of two centromere associated polypeptides by immunoblotting in connective tissue disease. Clin Exp Immunol (1988) 1.01
Elevated serum interleukin-6 levels associated with active disease in systemic connective tissue disorders. Clin Exp Rheumatol (1995) 0.99
Concentration of autoantibodies to native 60-kd Ro/SS-A and denatured 52-kd Ro/SS-A in eluates from the heart of a child who died with congenital complete heart block. Arthritis Rheum (1994) 0.99
CAMPATH-1H, a humanized monoclonal antibody, in refractory rheumatoid arthritis. An intravenous dose-escalation study. Arthritis Rheum (1995) 0.99
Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril. Arthritis Rheum (2007) 0.99
Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein. J Rheumatol (1978) 0.97
Eosinophilic fasciitis. Br J Rheumatol (1990) 0.97
Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: a serological and HLA study. Clin Exp Immunol (1994) 0.97
Autoantibodies to lipocortin-1 are associated with impaired glucocorticoid responsiveness in rheumatoid arthritis. J Rheumatol (1992) 0.95
Systemic lupus erythematosus in the elderly. J Rheumatol Suppl (1987) 0.94
Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis. Ann Rheum Dis (1988) 0.93
Antinuclear antibodies in the relatives and spouses of patients with systemic sclerosis. Ann Rheum Dis (1986) 0.93
Concentrations of glycosaminoglycans in synovial fluids and their relation with immunological and inflammatory mediators in rheumatoid arthritis. Ann Rheum Dis (1990) 0.93
Mononuclear phagocytes in rheumatoid arthritis: Fc-receptor expression by peripheral blood monocytes. Ann Rheum Dis (1984) 0.92
Frequency and clinical significance of anticentromere and anti Scl-70 antibodies in an English connective tissue disease population. Rheumatol Int (1983) 0.92
Xerotrachea and interstitial lung disease in primary Sjogren's syndrome. Respiration (1984) 0.92
Intra-articular variation of synovial changes in knee arthritis: biopsy study comparing changes in patellofemoral synovium and the medial tibiofemoral synovium. Br J Rheumatol (1987) 0.92
Antibodies to cellular antigens in Greek patients with autoimmune rheumatic diseases: anti-Ro(SSA) antibody a possible marker of penicillamine-D intolerance. Ann Rheum Dis (1984) 0.91
Structured approach to the investigation of anaemia in patients with rheumatoid arthritis. Ann Rheum Dis (1992) 0.90
Enhanced oxidative metabolism of neutrophils from patients with systemic sclerosis. Br J Rheumatol (1987) 0.90
Differential expression of the costimulatory molecules B7.1 (CD80) and B7.2 (CD86) in rheumatoid synovial tissue. Br J Rheumatol (1996) 0.90
HLA and immunoglobulin allotypes in mixed connective tissue disease. Arthritis Rheum (1988) 0.90
The association of primary biliary cirrhosis and systemic sclerosis is not accounted for by cross reactivity between mitochondrial and centromere antigens. J Autoimmun (1994) 0.90
Clinical and histological features of 'mechanic's hands' in a patient with antibodies to Jo-1--a case report. Clin Exp Dermatol (1994) 0.89
Generalised osteoarthritis: an evolutionary problem? Lancet (1987) 0.89
Cardiorespiratory responses to underwater treadmill walking in healthy females. Eur J Appl Physiol Occup Physiol (1998) 0.89
ANA-negative SLE. Clin Rheum Dis (1982) 0.89
Acute pseudogout of the temporomandibular joint: a report of three cases and review of the literature. Br J Rheumatol (1987) 0.88
Autoantibodies to mitochondrial and centromere antigens in primary biliary cirrhosis and systemic sclerosis. Clin Exp Immunol (1990) 0.87
Amyloidosis and systemic lupus erythematosus. Ann Rheum Dis (1984) 0.87
Giant cell arteritis precipitated by a diagnostic trial of prednisolone in suspected polymyalgia rheumatica. Clin Rheumatol (1987) 0.87
Lupus band test in untreated SLE patients: correlation of immunoglobulin deposition in the skin of the extensor forearm with clinical renal disease and serological abnormalities. J Invest Dermatol (1980) 0.86
Magnetic resonance imaging manifestations of idiopathic haemochromatosis in the wrist. Br J Rheumatol (1993) 0.86
Systemic response to local urate crystal induced inflammation in man: a possible model to study the acute phase response. Ann Rheum Dis (1985) 0.85
HLA-DO-related restriction fragment length polymorphisms in rheumatoid arthritis: evidence for a link with disease expression. Br J Rheumatol (1989) 0.85
Unusual cutaneous manifestations of systemic lupus erythematosus: I. Urticaria-like lesions. Correlation with clinical and serological abnormalities. J Invest Dermatol (1980) 0.85
Sclerotherapy as treatment of recurrent bleeding from upper gastrointestinal telangiectasia in CREST syndrome. Br J Rheumatol (1993) 0.85
The arthropathy of systemic sclerosis (scleroderma); comparison with mixed connective tissue disease. Clin Exp Rheumatol (1985) 0.85
Influence of non-steroidal anti-inflammatory drugs and disease activity on serum alkaline phosphatase concentrations in rheumatoid arthritis, osteoarthritis, and polymyalgia rheumatica. Ann Rheum Dis (1989) 0.84
Precipitating antibodies to nuclear antigens in systemic vasculitis. Clin Exp Immunol (1984) 0.84
Hydrocortisone induces lipocortin 1 production by peripheral blood mononuclear cells in vivo in man. Biochem Soc Trans (1990) 0.83
Magnetic resonance imaging of rheumatoid arthritis in metacarpophalangeal joints. Skeletal Radiol (2000) 0.83
Occurrence of antibodies to single-stranded DNA in ANA negative patients. Clin Exp Immunol (1979) 0.82
Preschool vegetarian children. Dietary and anthropometric data. J Am Diet Assoc (1980) 0.81
Predictors of the long-term outcome of early synovitis: a 5-year follow-up study. Br J Rheumatol (1991) 0.81
High-resolution magnetic resonance imaging of the interphalangeal joints of the hand. Skeletal Radiol (1991) 0.81
Rapid development of cerebral atrophy in systemic lupus erythematosus. Br J Rheumatol (1986) 0.81
Lupus anticoagulant: clinical significance in anticardiolipin positive patients with systemic lupus erythematosus. Ann Rheum Dis (1991) 0.81
D-penicillamine withdrawal in rheumatoid arthritis. Ann Rheum Dis (1984) 0.80
Autoantibodies to recombinant lipocortin-1 in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis (1989) 0.80
Comparative study of C reactive protein and serum amyloid A protein in experimental inflammation. Ann Rheum Dis (1991) 0.80
Salivary gland biopsy in sarcoidosis. Sarcoidosis (1989) 0.80
Limited joint mobility in diabetes mellitus. Ann Rheum Dis (1985) 0.80
HLA-DQB1 associations with anti-topoisomerase-1 antibodies in patients with systemic sclerosis and their first degree relatives. United Kingdom Systemic Sclerosis Study Group. J Autoimmun (1994) 0.80
Detection of antibodies to double stranded DNA and extractable nuclear antigen. J Clin Pathol (1987) 0.80
Anaemia of chronic disease in rheumatoid arthritis: effect of the blunted response to erythropoietin and of interleukin 1 production by marrow macrophages. Ann Rheum Dis (1992) 0.80
Intra-articular methotrexate in knee synovitis. Rheumatology (Oxford) (2004) 0.79
Osteosarcoma of breast recurring with mediastinal obstruction. Postgrad Med J (1984) 0.79
Spontaneous neutrophil activation in patients with primary Raynaud's phenomenon and systemic sclerosis. Br J Rheumatol (1992) 0.79
Thymopentin (TP-5) in the treatment of rheumatoid arthritis. Br J Rheumatol (1989) 0.79
Joint symptoms in relapsing polychondritis. Clin Exp Rheumatol (1995) 0.78
Hydralazine induced lupus syndrome with eye disease. Br Med J (Clin Res Ed) (1985) 0.78